Bender Robert & Associates
- SEC CIK
- 0000894300
- Latest filing
- Jul 30, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −12,202−100.0% | Sold out | Holders |
| Q4 2024 | 12,202 | $799.5K | 0.2% | −1,680−12.1% | Reduced | Holders |
| Q3 2024 | 13,882 | $1.08M | 0.2% | +13,882 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −18,813−100.0% | Sold out | Holders |
| Q1 2024 | 18,813 | $1.27M | 0.3% | −4,365−18.8% | Reduced | Holders |
| Q4 2023 | 23,178 | $1.56M | 0.4% | −5,441−19.0% | Reduced | Holders |
| Q3 2023 | 28,619 | $1.94M | 0.6% | −2,977−9.4% | Reduced | Holders |
| Q2 2023 | 31,596 | $2.26M | 0.6% | −12,664−28.6% | Reduced | Holders |
| Q1 2023 | 44,260 | $3.07M | 1.0% | +30+0.1% | Added | Holders |
| Q4 2022 | 44,230 | $3.00M | 1.1% | −2,185−4.7% | Reduced | Holders |
| Q3 2022 | 46,415 | $2.54M | 1.0% | +961+2.1% | Added | Holders |
| Q2 2022 | 45,454 | $3.00M | 1.1% | −884−1.9% | Reduced | Holders |
| Q1 2022 | 46,338 | $3.07M | 0.9% | −241−0.5% | Reduced | Holders |
| Q4 2021 | 46,579 | $2.80M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2021 | 46,579 | $2.80M | 0.8% | +46,579 | New | Holders |